- Research works
- 111 ▲ 193% vs 2013–17
- Citations
- 2.4k 21.9 per fractional work
- Top-10% rate
- 26.2% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Berry Oncology (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.5×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 6.5×
- Medicine 2.5×
- Pharmacology, Toxicology and Pharmaceutics 2.4×
- Neuroscience 2.3×
- Nursing 1.9×
- Agricultural and Biological Sciences 1.0×
- Immunology and Microbiology 0.8×
- Earth and Planetary Sciences 0.5×
- Environmental Science 0.2×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
Which keywords describe research at Berry Oncology (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Genetic Variants, Anemia, Sickle-cell Disease, Thalassemia, Clinical Genomics, Sequence Interpretation and Cell-Free DNA.
- Genetic Testing
- Cancer Progression
- Immunotherapy
- Prognostic Factors
- Genomic Sequencing
- Iron Regulation
- Genetic Mutations
- Tumor Microenvironment
- Cancer
- Prenatal Diagnosis
- Inflammation
- Cancer Genomics
- Genomic Instability
- Blood Groups
- Chemotherapy
- Pancreatic Cancer
- Clinical Genomics
- Thalassemia
- Anemia
- Targeted Therapy
- Epidemiology
- Genetic Variants
- Sickle-cell Disease
- Cell-Free DNA
- Sequence Interpretation
- Clinical Trials
- Alloimmunization
- Oxidative Stress
- ALK Inhibitors
- EGFR Mutations
- Mutational Signatures
- Gene Expression
- Iron Deficiency
- Erythropoiesis
- Hepcidin
- Aneuploidy Screening
- Maternal Plasma DNA Sequencing
- Breast Cancer
- Biomarkers
- Cancer Risk
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology6▲ 2.7×12 topics
- Targeted Therapy5▲ 44×3 topics
- Genetic Variants5▲ 51×5 topics
- Anemia4▲ 87×3 topics
- Sickle-cell Disease4▲ 184×1 topic
- Thalassemia4▲ 184×1 topic
- Cell-Free DNA4▲ 69×2 topics
- Clinical Genomics4▲ 200×1 topic
- Sequence Interpretation4▲ 200×1 topic
- Pancreatic Cancer3▲ 54×3 topics
- Clinical Trials3▲ 8.6×3 topics
- Chemotherapy3▲ 7.8×11 topics
- Alloimmunization3▲ 208×1 topic
- Blood Groups3▲ 208×1 topic
- Oxidative Stress2▲ 2.9×8 topics
- Genomic Instability2▲ 41×2 topics
- ALK Inhibitors2▲ 68×1 topic
- Cancer Genomics2▲ 58×1 topic
- EGFR Mutations2▲ 68×1 topic
- Inflammation2▲ 2.0×10 topics
- Mutational Signatures2▲ 58×1 topic
- Prenatal Diagnosis2▲ 26×3 topics
- Gene Expression2▲ 6.1×11 topics
- Cancer2▲ 2.5×11 topics
- Iron Deficiency2▲ 61×2 topics
- Tumor Microenvironment2▲ 7.4×5 topics
- Erythropoiesis2▲ 49×2 topics
- Genetic Mutations2▲ 7.2×7 topics
- Hepcidin2▲ 73×1 topic
- Iron Regulation2▲ 73×1 topic
- Aneuploidy Screening1▲ 100×1 topic
- Genomic Sequencing1▲ 23×2 topics
- Maternal Plasma DNA Sequencing1▲ 100×1 topic
- Prognostic Factors1▲ 5.9×7 topics
- Breast Cancer1▲ 10.0×3 topics
- Immunotherapy1▲ 3.2×3 topics
- Biomarkers1▲ 3.0×6 topics
- Cancer Progression1▲ 12×3 topics
- Cancer Risk1▲ 8.8×2 topics
- Genetic Testing1▲ 17×2 topics
Which research topics does Berry Oncology (China) publish most on?
By volume in 2022–2025: Hemoglobinopathies and Related Disorders, Genomics and Rare Diseases, Blood groups and transfusion and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemoglobinopathies and Related Disorders Genetics 4 works
- 2 Genomics and Rare Diseases Genetics 4 works
- 3 Blood groups and transfusion Hematology 3 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 5 Cancer Genomics and Diagnostics Cancer Research 2 works
- 6 Iron Metabolism and Disorders Hematology 2 works
- 7 Prenatal Screening and Diagnostics Pediatrics, Perinatology and Child Health 1 works
- 8 RNA modifications and cancer Molecular Biology 1 works
- 9 Genomic variations and chromosomal abnormalities Genetics 1 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Berry Oncology (China)'s research output changed?
Output in 2018–2022 was 193% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Fuzhou
- Fuzhou University
- Fujian Normal University
- Fujian Medical University
- Fujian Agriculture and Forestry University
- Union Hospital
- Fujian Institute of Research on the Structure of Matter
- Fujian University of Technology
- Minjiang University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.